VP, Clinical Operations and Development
Sound Pharmaceuticals, Inc
Seattle, WA, United States
Jacqueline Nguyen is an accomplished clinical operations and program development professional with extensive experience and successful leadership in all aspects of clinical trials and organizational management. Experienced in managing and auditing Phase I-IV clinical trials including pharmaceutical projects (blinded and unblinded), investigator-initiated projects, NIH funded and cooperative group projects. She has extensive experience consulting and leading operation group, CRO’s cross-functional teams, specialty group practices, and academic institutions for global clinical trials. Therapeutic Experience: hypertension, diabetes, oncology (gynecology, breast, head and neck, hematology, and bone marrow transplant), rheumatology (rheumatoid and psoriatic arthritis, osteoarthritis, lupus, fibromyalgia, gout, and polymyalgia rheumatica), Meniere’s disease, cystic fibrosis, and COVID-19.
About Sound Pharmaceuticals, Inc (SPI). A privately held biotechnology company focuses on developing therapeutics to address patients with significant unmet medical needs in the space of sensorineural otologic diseases. SPI is testing SPI-1005 under four other active Investigational New Drug Applications involving several neurotologic indications including aminoglycoside-induced ototoxicity co-funded by the CF Foundation and COVID-19 inpatients co-funded by the NIH. The leadership team consists of Jonathan Kil, MD, Co-Founder and CEO, Jacqueline Nguyen, MBA, VP Clinical Operations and Development, John Sullivan, MBA, CFO, and G. Michael Wall, PhD, VP Pharmaceutical Development. Details of the SPI-1005 clinical trials can be viewed online at www.clinicaltrials.gov or by visiting www.soundpharma.com.
Disclosure information not submitted.
Understanding the Placebo Effect in Clinical Trials for Ménière Disease
Monday, October 2, 2023
8:48 AM - 8:54 AM East Coast USA Time